相关实验视频

Updated: May 29, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

来自瘤B细胞的IL-10调节了扩散的大B细胞淋巴瘤微环境和对免疫治疗的反应

Marcos Garcia-Lacarte¹, Sara C Grijalba¹, Javier Melchor Sánchez²

¹Universidad de Navarra, Pamplona, Spain.

|February 3, 2025

概括

矛盾的是,来自B细胞的互白素-10 (IL-10) 恶化了扩散型大B细胞淋巴瘤 (DLBCL) 的结果,但其缺失增强了抗CD20治疗的敏感性. 这项研究揭示了IL-10在塑造瘤微环境和免疫治疗反应方面的复杂作用.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
分子生物学分子生物学

背景情况:

由瘤B细胞分泌的互白素-10 (IL-10) 在扩散性大B细胞淋巴瘤 (DLBCL) 进展中起作用.
IL-10对瘤微环境的确切贡献及其对激活B细胞样 (ABC) DLBCL免疫治疗的影响尚不清楚.

研究的目的:

研究B细胞衍生IL-10在ABC-DLBCL微环境中的功能和机制作用.
确定恶性B细胞中IL-10缺乏对淋巴瘤进展和免疫治疗反应的影响.

主要方法:

在恶性B细胞中产生ABC-DLBCL的免疫能力较强的小鼠模型, IL-10的条件淘汰.
评估瘤进展,生存,免疫微环境,以及对抗CD20免疫疗法和调控性T细胞枯竭的反应.
对IL-10对恶性B细胞和瘤微环境的自身蛋白和蛋白信号效应的分析.

主要成果:

缺少IL-10的ABC-DLBCL小鼠具有矛盾的生存率较低,但对抗CD20免疫疗法和T细胞枯竭的敏感性增加.
缺少IL-10导致免疫抑制,T细胞耗尽的微环境,血管生成增加,使淋巴瘤难以抵抗PD-1阻塞.
在IL-10缺乏的小鼠中,对抗CD20免疫疗法的增强反应与B细胞中升调的通道有关.

结论:

B细胞衍生的IL-10具有双重作用:自身隐性信号促进恶性B细胞的生存,而副隐性作用维持一个免疫反应微环境,这对免疫疗法的有效性至关重要.
与IL-10相关的转录特征可以预测使用R-CHOP治疗的DLBCL患者的临床结果.
了解IL-10的复杂作用对于开发针对DLBCL微环境的有效免疫疗法至关重要.

更多相关视频

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

相关概念视频

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

T Cell Types and Functions

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...